Form 8-K - Current report:
SEC Accession No. 0000950120-08-000254
Filing Date
2008-06-04
Accepted
2008-06-04 16:19:46
Documents
2
Period of Report
2008-05-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm 8-K 25307
2 PRESS RELEASE exh99.htm EX-99.1 5582
  Complete submission text file 0000950120-08-000254.txt   32380
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19879 | Film No.: 08880835
SIC: 2834 Pharmaceutical Preparations